Skip to content
About us
Our DNA
Board members
Our leadership
Partners
Pipeline
VTX-801 – Wilson’s disease
> VTX-801 in Wilson disease – GATEWAY – Phase 1/2 Clinical Trial
VTX-802 & VTX-803 – PFIC
VTX-804 – Citrullinemia Type 1
VTX–806 – Cerebrotendinous Xanthomatosis
Investors
News
Events
Patients & Families
Patient’s Stories
Patient advocacy
Patient & Families ressources
Compassionate Use and Expanded Access
Work at Vivet
Menu
About us
Our DNA
Board members
Our leadership
Partners
Pipeline
VTX-801 – Wilson’s disease
> VTX-801 in Wilson disease – GATEWAY – Phase 1/2 Clinical Trial
VTX-802 & VTX-803 – PFIC
VTX-804 – Citrullinemia Type 1
VTX–806 – Cerebrotendinous Xanthomatosis
Investors
News
Events
Patients & Families
Patient’s Stories
Patient advocacy
Patient & Families ressources
Compassionate Use and Expanded Access
Work at Vivet
Board members
Our DNA
>
Board members
>
Our leadership
>
Partners
>
Chairman of the Board
Eduardo Bravo, MBA
Co-founder & CEO
Jean-Philippe Combal, PharmD, PhD
Pfizer Ventures
Rana Al-Hallaq
Kurma Partners
Amanda Gett-Chaperot, PhD, MBA
Roche Venture Fund
Carole Nuechterlein
Columbus Venture Partners
Javier García, MBA
HealthCap
Mårten Steen, MD, PhD
Novartis Venture Fund
Beat Steffen, MD, MBA
Ysios Capital
Karen Wagner, PhD
